Adjuvant dendritic cell based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: Rationale and design of the MESOPEC study. Issue 2 (February 2019) - De Boer, N.; van Kooten, J.; Brandt, A.; Verhoef, C.; Burger, P.; Aerts, J.; Madsen, E.